
|Articles|April 25, 2019
Urology Times Program Director Panel
Advertisement
Urology Times is the leader in clinical analysis and perspective for practicing urologists. But now, we have more content tailored to residents than ever. Take the next step and join our Program Director Panel to help us shape content for young doctors.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
2
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
3
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
4
Optimizing care for men with overactive bladder, with Keith Xavier, MD
5








